BOB体育

Skip to main content
(352) 273-9400

Ginger Clark, MD, MS : Research

Gastroenterologist, Transplant Hepatologist

Photo of Ginger Clark
(352) 273-9400 MyUFHealth

Research at a glance

Top areas of exploration

  • Liver Cirrhosis , 8 publications
  • Hepatitis C , 8 publications
  • alpha 1-Antitrypsin Deficiency , 6 publications
  • Antiviral Agents , 6 publications

Research activity

42 publications

1,188 citations

Why is this important?

Active clinical trials

BIO89-100-132 The ENLIGHTEN-Cirrhosis Study

The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH [previously known as nonalcoholic steatohepatitis, NASH]).

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
TAK-999-3003

The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein. People who have taken part in previous fazirsiran studies (AROAAT2001鈥�

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

42 publications

2019

Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD.

Journal of critical care

鈥�

2019

Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

鈥�

2018

Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.

Journal of hepatology

鈥�

2018

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

鈥�

2017

Evaluating the Efficacy of a Registry linked to a Consent to Re-Contact Program and Communication Strategies for Recruiting and Enrolling Participants into Clinical Trials.

Contemporary clinical trials communications

鈥�